Joerg Ermann
Overview
Explore the profile of Joerg Ermann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
2484
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choufani M, Ghusn W, Dubreuil M, Ermann J
J Rheumatol
. 2025 Mar;
PMID: 40089303
Objective: To examine demographic and geographic diversity in axial spondyloarthritis (axSpA) drug trials. Methods: We performed a descriptive epidemiological study using ClinicalTrials.gov data. We included completed phase II-IV drug trials...
2.
Jan R, Hong S, Ermann J
Curr Rheumatol Rep
. 2025 Feb;
27(1):17.
PMID: 39891807
Purpose Of Review: There is an unmet need to adequately identify, describe and treat the musculoskeletal manifestations of patients with inflammatory bowel disease (IBD). At the 2024 SPARTAN annual meeting,...
3.
Hong S, Dalal R, Kuhn K, Stahly A, Scott F, Scott F, et al.
Am J Gastroenterol
. 2025 Jan;
PMID: 39760386
Introduction: Spondyloarthritis (SpA), the most common extraintestinal manifestation of inflammatory bowel disease (IBD), is reported in up to 39% of patients with IBD. Despite this high prevalence, risk factors of...
4.
Ermann J, Hong S, Stahly A, Dalal R, Malik F, Scott F, et al.
Arthritis Care Res (Hoboken)
. 2025 Jan;
PMID: 39748206
Objective: Spondyloarthritis (SpA) is the most common extraintestinal manifestation of inflammatory bowel disease (IBD). The application of screening tools to detect SpA in patients with IBD may lead to earlier...
5.
Choufani M, Ermann J
Curr Rheumatol Rep
. 2024 Dec;
27(1):8.
PMID: 39680252
Purpose Of Review: Since the publication of the 2019 American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network (ACR/SAA/SPARTAN) treatment recommendations for ankylosing spondylitis (AS) and nonradiographic axial...
6.
7.
Chinas M, Fernandez-Salinas D, Aguiar V, Nieto-Caballero V, Lefton M, Nigrovic P, et al.
HGG Adv
. 2024 Oct;
6(1):100375.
PMID: 39468794
Multiple lines of evidence indicate that ankylosing spondylitis (AS) is a lymphocyte-driven disease. However, which lymphocyte populations are critical in AS pathogenesis is not known. In this study, we aimed...
8.
Falloon K, Dossaji Z, Mude P, Abushamma S, Ananthakrishnan A, Barnes E, et al.
Inflamm Bowel Dis
. 2024 Jun;
31(3):812-842.
PMID: 38836521
Background: Inflammatory bowel disease (IBD)-associated peripheral spondyloarthritis (pSpA) decreases quality of life and remains poorly understood. Given the prevalence of this condition and its negative impact, it is surprising that...
9.
Joshi N, Yan J, Dang M, Slaughter K, Wang Y, Wu D, et al.
bioRxiv
. 2024 Jun;
PMID: 38826308
Intra-articular delivery of disease-modifying osteoarthritis drugs (DMOADs) is likely to be most effective in early post-traumatic osteoarthritis (PTOA) when symptoms are minimal and patients are physically active. DMOAD delivery systems...
10.
Choufani M, Kay J, Ermann J
Curr Opin Rheumatol
. 2024 Apr;
36(4):251-260.
PMID: 38661436
Purpose Of Review: This review discusses international clinical practice guidelines (CPGs) for axial spondyloarthritis (axSpA) focusing on methodology, guideline quality, and implementation. Recent Findings: The Assessment of SpondyloArthritis International Society/European...